Analysis of the subsequent treatment of osteoporosis by transitioning from bisphosphonates to denosumab, using quantitative computed tomography: A prospective cohort study

PURPOSE: Denosumab reduces bone resorption and improves bone mineral density (BMD). Studies have analyzed subsequent treatment transitioning from bisphosphonates to denosumab based on dual-energy X-ray absorptiometry scanning (DXA). Quantitative computed tomography (QCT) can help assess cortical and...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsuchiya, Koki, Ishikawa, Koji, Kudo, Yoshifumi, Tani, Soji, Nagai, Takashi, Toyone, Tomoaki, Inagaki, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170107/
https://www.ncbi.nlm.nih.gov/pubmed/34113694
http://dx.doi.org/10.1016/j.bonr.2021.101090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170107/
https://www.ncbi.nlm.nih.gov/pubmed/34113694
http://dx.doi.org/10.1016/j.bonr.2021.101090

Ejemplares similares